BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14294237)

  • 1. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 3. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
    BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
    Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on ceruloplasmin in Wilson's disease.
    SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
    J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
    [No Abstract]   [Full Text] [Related]  

  • 5. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic aspects of Wilson's disease: a review.
    SIMPSON JF
    Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
    [No Abstract]   [Full Text] [Related]  

  • 7. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
    HELLER GL
    Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
    BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
    Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 10. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 11. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH; GITLIN D
    Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
    [No Abstract]   [Full Text] [Related]  

  • 13. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-biological considerations on a case of Wilson's disease with normal ceruloplasmin levels].
    REBUCCI GG; TASSINARI CA
    Riv Patol Nerv Ment; 1962 Sep; 83():498-518. PubMed ID: 13973459
    [No Abstract]   [Full Text] [Related]  

  • 15. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruloplasmin, copper and Wilson's disease.
    KAWAI T
    Bull Univ Miami Sch Med Jackson Meml Hosp; 1962; 16():89-96. PubMed ID: 14031483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnosis of Wilson's disease in asymptomatic patients.
    STERNLIEB I; SCHEINBERG IH
    JAMA; 1963 Mar; 183():747-50. PubMed ID: 13983986
    [No Abstract]   [Full Text] [Related]  

  • 20. Wilson's disease and the concentration of caeruloplasmin in serum.
    SCHEINBERG IH; STERNLIEB I
    Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.